RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy prior to resection of colorectal liver metastases

Lignende værker

• RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases
  af: Vauthey, Jean-Nicolas, et al.
  Udgivet: (2013)
• Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point Before Resection of Hepatic Colorectal Metastases
  af: Shindoh, Junichi, et al.
  Udgivet: (2012)
• RAS mutation predicts positive resection margins and narrower resection margins in patients undergoing resection of colorectal liver metastases
  af: Brudvik, Kristoffer Watten, et al.
  Udgivet: (2016)
• Margin Status Remains an Important Determinant of Survival after Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy
  af: Andreou, Andreas, et al.
  Udgivet: (2013)
• Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases
  af: Andreou, Andreas, et al.
  Udgivet: (2012)